It’s fitting, given the edginess over the election, that Halloween is falling only a few days before election day so here is a list of recommended stem cell reads for you to dive into some biomedical science. Liver buds from stem cells Generation of human induced pluripotent stem cell-derived liver buds with chemically defined and […]
Stem cell reads: liver buds, MSCs, SMARC, more Read More »
Last week I wrote a long post detailing the troubling multimillion-dollar reverberations between the Duke Autism Center and a for-profit stem cell clinic. The clinic in Panama is The Stem Cell Institute. The potential entanglements raise a bunch of questions and concerns. They center on questionable, unproven autism “treatments”. In Duke’s case, their own clinical
More Duke Autism Center backstory: stem cell ‘magic’ & money Read More »
IPS cell research is a growing area of promise for regenerative medicine. These stem cells, also known as iPSCs or more formally as Induced Pluripotent Stem Cells, are engineered cells that are programmed to function the same way as embryonic stem cells. They can be differentiated into possibly any type of cell that is needed for
Overview of IPS cell prospects for clinical impact Read More »
Maybe we can use science as an escape from politics during the last week or so before the election? I hope so. Here are my weekly recommended reads. Several papers ended up relating to nucleus, cell and embryo size and space as well as chromatin, which is very interesting. Cell and chromatin biology pubs, media
Weekly science reads: CRISPR, stem cells, cell size & space, more Read More »
It’s encouraging to see that the states including now Arkansas via their attorney generals (or is it attorneys general?) are taking more action against stem cell clinic firms, but the big scope of AG action has somewhat surprised me. Arkansas AG suit The latest AG action on a stem cell clinic type firm comes from
Arkansas adds to wave of state AG actions vs. stem cell clinics Read More »
Are Trump and the Republican Party showing major hypocrisy over Trump’s use of experimental COVID-19 therapies in part developed by Regeneron using embryonic and fetal cells? The Internet is kind of blowing up over this. Trump’s collision with stem cells For example, people are directly confronting Trump on Twitter over his recent all caps tweet
Trump, GOP hypocrisy on Regeneron COVID-19 fetal, stem cell work Read More »
Here are some recommended stem cell and other reads for the week ranging from COVID developments to prosecutors finally catching up with a stem cell surgeon who had many patients die to a list of interesting pubs. Because Trump now has COVID, I wondered on Friday if he might consider trying unproven stem cells or
Recommended reads: Yamanaka review, stem cell indictment, COVID, MYC, more Read More »
What a difference one day can make including in the types of questions I’m getting with this one rising to the top: should President Donald Trump get stem cells for his COVID-19? Whether he should or not, will he get them? This is more than a hypothetical as a surprising number of people in Trump’s
Will Trump get stem cells for COVID-19? Read More »
In my view, it seems likely that the FDA has opened a big can of worms by starting to clear the COVID-19 trials and programs of for-profit stem cell clinics and other related firms. OK to Stemedica trial The FDA just approved another such effort, this one by the firm Stemedica. You can read more about
FDA OK’s more COVID-19 efforts of unproven stem cell clinics Read More »
Drugs that restore the shape of the errant protein behind cystic fibrosis (CF) have, over the past eight years, helped the majority of patients, who have certain mutations. Gene-corrected stem cells might offer a “mutation agnostic” option to CF. CF results from a glitch in a glycoprotein with the unwieldy name “cystic fibrosis transmembrane conductance
Can Gene-Edited Stem Cells Treat Cystic Fibrosis? Read More »